Add to ORKGSafety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long
OBJECTIVE: To compare the effectiveness and safety of three types of stents (sirolimus eluting, pacl...
Several studies have shown Drug Eluting Stents (DES) to be better compared to Bare Metal Stents (BMS...
To examine whether polymer based coronary stents eluting sirolimus or paclitaxel are equally effecti...
Patients with diabetes mellitus have more extensive coronary artery disease, more disease progressio...
Background: Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, ...
INTRODUCTION AND OBJECTIVES: The performance of drug-eluting stents (DESs) in high-risk patients wit...
ObjectivesOur aim was to evaluate restenosis rate of drug-eluting stents (DES) in patients with and ...
The two pivotal U.S. trials of drug-eluting stents do not establish the principle that these stents ...
Background: Diabetes mellitus (DM) is a well-known risk factor for adverse cardiovascular events in ...
ABSTRACTBackgroundThe percutaneous treatment of coronary artery disease has been revolutionized by t...
In diabetic patients, the use of drug-eluting stents (paclitaxel-PES or sirolimus-SES) reduces the r...
Background: Few data are available on diabetic patients undergoing percutaneous coronary interventio...
Background: Few data are available on diabetic patients undergoing percutaneous coronary interventio...
ObjectivesThis study sought to evaluate the safety and efficacy of drug-eluting stents (DES) compare...
ABSTRACTBackgroundPercutaneous revascularization in diabetic is frequent and the use of drug-eluting...
OBJECTIVE: To compare the effectiveness and safety of three types of stents (sirolimus eluting, pacl...
Several studies have shown Drug Eluting Stents (DES) to be better compared to Bare Metal Stents (BMS...
To examine whether polymer based coronary stents eluting sirolimus or paclitaxel are equally effecti...
Patients with diabetes mellitus have more extensive coronary artery disease, more disease progressio...
Background: Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, ...
INTRODUCTION AND OBJECTIVES: The performance of drug-eluting stents (DESs) in high-risk patients wit...
ObjectivesOur aim was to evaluate restenosis rate of drug-eluting stents (DES) in patients with and ...
The two pivotal U.S. trials of drug-eluting stents do not establish the principle that these stents ...
Background: Diabetes mellitus (DM) is a well-known risk factor for adverse cardiovascular events in ...
ABSTRACTBackgroundThe percutaneous treatment of coronary artery disease has been revolutionized by t...
In diabetic patients, the use of drug-eluting stents (paclitaxel-PES or sirolimus-SES) reduces the r...
Background: Few data are available on diabetic patients undergoing percutaneous coronary interventio...
Background: Few data are available on diabetic patients undergoing percutaneous coronary interventio...
ObjectivesThis study sought to evaluate the safety and efficacy of drug-eluting stents (DES) compare...
ABSTRACTBackgroundPercutaneous revascularization in diabetic is frequent and the use of drug-eluting...
OBJECTIVE: To compare the effectiveness and safety of three types of stents (sirolimus eluting, pacl...
Several studies have shown Drug Eluting Stents (DES) to be better compared to Bare Metal Stents (BMS...
To examine whether polymer based coronary stents eluting sirolimus or paclitaxel are equally effecti...